QCM
ANAB icon

Quantinno Capital Management’s AnaptysBio ANAB Stock Holding History

Quantinno Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Buy
6,547
+463
+8% +$28.1K ﹤0.01% 3040
2026
Q1 		$337K Sell
6,084
-350
-5% -$18.8K ﹤0.01% 2968
2025
Q4 		$312K Buy
+6,434
New +$251K ﹤0.01% 2808

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Quantinno Capital Management's ANAB Position: Q2 2026 in Review

Quantinno Capital Management increased its AnaptysBio (ANAB) stake by 7.6% in Q2 2026, buying an estimated $28.1K and bringing the position to 6,547 shares worth $442K. The position accounts for ﹤0.01% of the portfolio, ranked #3040.

Quantinno Capital Management first reported a position in ANAB in Q4 2025 and has held it in 3 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Quantinno Capital Management held 6,547 shares of AnaptysBio worth $442K as of Q2 2026.
  • Quantinno Capital Management bought 463 AnaptysBio shares in Q2 2026, an estimated $28.1K.
  • AnaptysBio made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3040 holding.
  • Quantinno Capital Management first reported a position in AnaptysBio in Q4 2025 and has held it in 3 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.